PURPOSE: It is still unknown whether left ventricular ejection fraction (LVEF) might affect the magnitude of improvement after atrial fibrillation (AF) ablation on cardiac function in persistent or longstanding persistent AF (CAF) patients. METHOD: We performed echocardiography in 35 patients with CAF before and after catheter ablation (CA). Patients were stratified by LVEF into two groups prior to CA-normal LVEF (≥50 % LVEF, N group, n = 24) and a low LVEF group (<50 % LVEF, L group, n = 11). Patients were followed at 1 month, 3 months, 6 months, 1 year, and 2 years after ablation. RESULTS: After 15.8 ± 7.4 months follow-up, the L group showed greater improvement in LVEF and left atrial ejection fraction (LAEF; N group vs L group: LVEF difference (%), 5 ±8 vs 20± 13, p < 0.01; LAEF difference (%), 11 ± 12 vs 21 ± 10, p < 0.05). LA maximal volume and E/e' showed the same tendency after ablation, although the extent of improvement was not statistically significant. Both groups showed almost the same time course of improvement up to 2 years, although the L group showed earlier recovery in LVEF. CONCLUSION: The greater improvement in several cardiac functions was seen in patients with greater LV dysfunction, after the CA for CAF.
PURPOSE: It is still unknown whether left ventricular ejection fraction (LVEF) might affect the magnitude of improvement after atrial fibrillation (AF) ablation on cardiac function in persistent or longstanding persistent AF (CAF) patients. METHOD: We performed echocardiography in 35 patients with CAF before and after catheter ablation (CA). Patients were stratified by LVEF into two groups prior to CA-normal LVEF (≥50 % LVEF, N group, n = 24) and a low LVEF group (<50 % LVEF, L group, n = 11). Patients were followed at 1 month, 3 months, 6 months, 1 year, and 2 years after ablation. RESULTS: After 15.8 ± 7.4 months follow-up, the L group showed greater improvement in LVEF and left atrial ejection fraction (LAEF; N group vs L group: LVEF difference (%), 5 ±8 vs 20± 13, p < 0.01; LAEF difference (%), 11 ± 12 vs 21 ± 10, p < 0.05). LA maximal volume and E/e' showed the same tendency after ablation, although the extent of improvement was not statistically significant. Both groups showed almost the same time course of improvement up to 2 years, although the L group showed earlier recovery in LVEF. CONCLUSION: The greater improvement in several cardiac functions was seen in patients with greater LV dysfunction, after the CA for CAF.
Authors: Atul Verma; Fethi Kilicaslan; James R Adams; Steven Hao; Salwa Beheiry; Stephen Minor; Volkan Ozduran; Samy Claude Elayi; David O Martin; Robert A Schweikert; Walid Saliba; James D Thomas; Mario Garcia; Allan Klein; Andrea Natale Journal: J Cardiovasc Electrophysiol Date: 2006-07
Authors: Kristina Lemola; Benoit Desjardins; Michael Sneider; Ian Case; Aman Chugh; Eric Good; Jihn Han; Kamala Tamirisa; Ariane Tsemo; Scott Reich; David Tschopp; Petar Igic; Darryl Elmouchi; Frank Bogun; Frank Pelosi; Ella Kazerooni; Fred Morady; Hakan Oral Journal: Heart Rhythm Date: 2005-09 Impact factor: 6.343
Authors: Rukshen Weerasooriya; Paul Khairy; Jean Litalien; Laurent Macle; Meleze Hocini; Frederic Sacher; Nicolas Lellouche; Sebastien Knecht; Matthew Wright; Isabelle Nault; Shinsuke Miyazaki; Christophe Scavee; Jacques Clementy; Michel Haissaguerre; Pierre Jais Journal: J Am Coll Cardiol Date: 2011-01-11 Impact factor: 24.094
Authors: Philip J Gentlesk; William H Sauer; Edward P Gerstenfeld; David Lin; Sanjay Dixit; Erica Zado; David Callans; Francis E Marchlinski Journal: J Cardiovasc Electrophysiol Date: 2006-11-01
Authors: Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin Journal: Circulation Date: 2003-05-27 Impact factor: 29.690
Authors: Laurens F Tops; Dennis W Den Uijl; Victoria Delgado; Nina Ajmone Marsan; Katja Zeppenfeld; Eduard Holman; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax Journal: Circ Arrhythm Electrophysiol Date: 2009-04-17
Authors: Daniel Addison; Hoshang Farhad; Ravi V Shah; Thomas Mayrhofer; Siddique A Abbasi; Roy M John; Gregory F Michaud; Michael Jerosch-Herold; Udo Hoffmann; William G Stevenson; Raymond Y Kwong; Tomas G Neilan Journal: J Am Heart Assoc Date: 2016-09-26 Impact factor: 5.501